tubercidin has been researched along with Ebola Hemorrhagic Fever in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bray, M; Huggins, J; Zhang, ZX | 1 |
| Bray, M; Driscoll, J; Huggins, JW | 1 |
2 other study(ies) available for tubercidin and Ebola Hemorrhagic Fever
| Article | Year |
|---|---|
Antiviral drug therapy of filovirus infections: S-adenosylhomocysteine hydrolase inhibitors inhibit Ebola virus in vitro and in a lethal mouse model.
Topics: Adenosylhomocysteinase; Animals; Antiviral Agents; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation; Drug Evaluation, Preclinical; Ebolavirus; Enzyme Inhibitors; Hemorrhagic Fever, Ebola; Hydrolases; In Vitro Techniques; Liver; Mice; Mice, Inbred BALB C; Spleen; Time Factors; Tubercidin; Vero Cells | 1999 |
Treatment of lethal Ebola virus infection in mice with a single dose of an S-adenosyl-L-homocysteine hydrolase inhibitor.
Topics: Adenosine; Adenosylhomocysteinase; Animals; Antiviral Agents; Cell Line; Dose-Response Relationship, Drug; Ebolavirus; Enzyme Inhibitors; Female; Hemorrhagic Fever, Ebola; Hydrolases; Mice; Mice, Inbred BALB C; Mice, SCID; S-Adenosylhomocysteine; Tubercidin | 2000 |